241 related articles for article (PubMed ID: 29128993)
1. Pancreatic adenocarcinoma: cross-sectional imaging techniques.
Kulkarni NM; Hough DM; Tolat PP; Soloff EV; Kambadakone AR
Abdom Radiol (NY); 2018 Feb; 43(2):253-263. PubMed ID: 29128993
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic adenocarcinoma: diagnosis and staging using multidetector-row computed tomography (MDCT) and magnetic resonance imaging (MRI).
Francis IR
Cancer Imaging; 2007 Oct; 7 Spec No A(Special issue A):S160-5. PubMed ID: 17921087
[TBL] [Abstract][Full Text] [Related]
3. Imaging of pancreatic adenocarcinoma: update on staging/resectability.
Tamm EP; Balachandran A; Bhosale PR; Katz MH; Fleming JB; Lee JH; Varadhachary GR
Radiol Clin North Am; 2012 May; 50(3):407-28. PubMed ID: 22560689
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT.
Schima W; Függer R; Schober E; Oettl C; Wamser P; Grabenwöger F; Ryan JM; Novacek G
AJR Am J Roentgenol; 2002 Sep; 179(3):717-24. PubMed ID: 12185052
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced MR imaging and dual-phase helical CT in the preoperative assessment of suspected pancreatic cancer: a comparative study with receiver operating characteristic analysis.
Sheridan MB; Ward J; Guthrie JA; Spencer JA; Craven CM; Wilson D; Guillou PJ; Robinson PJ
AJR Am J Roentgenol; 1999 Sep; 173(3):583-90. PubMed ID: 10470884
[TBL] [Abstract][Full Text] [Related]
6. Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT.
Motosugi U; Ichikawa T; Morisaka H; Sou H; Muhi A; Kimura K; Sano K; Araki T
Radiology; 2011 Aug; 260(2):446-53. PubMed ID: 21693662
[TBL] [Abstract][Full Text] [Related]
7. CT and MR imaging of pancreatic cancer.
Ishiguchi T; Ota T; Naganawa S; Fukatsu H; Itoh S; Ishigaki T
Hepatogastroenterology; 2001; 48(40):923-7. PubMed ID: 11490841
[TBL] [Abstract][Full Text] [Related]
8. Comparison of helical CT and MR imaging in detecting and staging small pancreatic adenocarcinoma.
Irie H; Honda H; Kaneko K; Kuroiwa T; Yoshimitsu K; Masuda K
Abdom Imaging; 1997; 22(4):429-33. PubMed ID: 9157866
[TBL] [Abstract][Full Text] [Related]
9. Single-source dual-energy spectral multidetector CT of pancreatic adenocarcinoma: optimization of energy level viewing significantly increases lesion contrast.
Patel BN; Thomas JV; Lockhart ME; Berland LL; Morgan DE
Clin Radiol; 2013 Feb; 68(2):148-54. PubMed ID: 22889459
[TBL] [Abstract][Full Text] [Related]
10. Local extension of pancreatic carcinoma: assessment with thin-section helical CT versus with breath-hold fast MR imaging--ROC analysis.
Nishiharu T; Yamashita Y; Abe Y; Mitsuzaki K; Tsuchigame T; Nakayama Y; Takahashi M
Radiology; 1999 Aug; 212(2):445-52. PubMed ID: 10429702
[TBL] [Abstract][Full Text] [Related]
11. Surgical resectability of pancreatic adenocarcinoma: CTA.
Wong JC; Raman S
Abdom Imaging; 2010 Aug; 35(4):471-80. PubMed ID: 19468791
[TBL] [Abstract][Full Text] [Related]
12. Resectability of pancreatic adenocarcinoma: assessment using multidetector-row computed tomography with multiplanar reformations.
Manak E; Merkel S; Klein P; Papadopoulos T; Bautz WA; Baum U
Abdom Imaging; 2009; 34(1):75-80. PubMed ID: 17934772
[TBL] [Abstract][Full Text] [Related]
13. Radiologic staging of pancreatic adenocarcinoma.
Nghiem HV; Freeny PC
Radiol Clin North Am; 1994 Jan; 32(1):71-9. PubMed ID: 8284362
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive preoperative assessment of pancreatic adenocarcinoma with 64-section volumetric CT.
Brennan DD; Zamboni GA; Raptopoulos VD; Kruskal JB
Radiographics; 2007; 27(6):1653-66. PubMed ID: 18025509
[TBL] [Abstract][Full Text] [Related]
15. Potentially resectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation.
Bluemke DA; Cameron JL; Hruban RH; Pitt HA; Siegelman SS; Soyer P; Fishman EK
Radiology; 1995 Nov; 197(2):381-5. PubMed ID: 7480681
[TBL] [Abstract][Full Text] [Related]
16. Tumor-node-metastasis staging of pancreatic adenocarcinoma.
Katz MH; Hwang R; Fleming JB; Evans DB
CA Cancer J Clin; 2008; 58(2):111-25. PubMed ID: 18272835
[TBL] [Abstract][Full Text] [Related]
17. Mangafodipir-DPDP enhanced MRI visualization of a pancreatic adenocarcinoma previously undetected by extracellular contrast enhanced CT and MRI.
De Filippo M; Bocchi C; Quartieri L; Corradi D; Zompatori M
Acta Biomed; 2007 Dec; 78(3):225-8. PubMed ID: 18330084
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic adenocarcinoma: MDCT versus MRI in the detection and assessment of locoregional extension.
Mehmet Erturk S; Ichikawa T; Sou H; Saitou R; Tsukamoto T; Motosugi U; Araki T
J Comput Assist Tomogr; 2006; 30(4):583-90. PubMed ID: 16845288
[TBL] [Abstract][Full Text] [Related]
19. MRI evaluation of pancreatic ductal adenocarcinoma: diagnosis, mimics, and staging.
Bowman AW; Bolan CW
Abdom Radiol (NY); 2019 Mar; 44(3):936-949. PubMed ID: 29967986
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic adenocarcinoma: variability in measurements of tumor size among computed tomography, magnetic resonance imaging, and pathologic specimens.
Ma C; Yang P; Li J; Bian Y; Wang L; Lu J
Abdom Radiol (NY); 2020 Mar; 45(3):782-788. PubMed ID: 31292672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
